Eikon Therapeutics files for IPO, testing biotech rallynews2026-01-09T22:14:35+00:00January 9th, 2026|Endpoints News|
Krystal Biotech says it can deliver native protein to cystic fibrosis patientsnews2026-01-09T15:26:44+00:00January 9th, 2026|Endpoints News|
Roche returns to Chinese biotech MediLink for another ADC pactnews2026-01-09T13:15:44+00:00January 9th, 2026|Endpoints News|
Enliven’s Phase 1 leukemia pill data look competitive with Novartis and Ternsnews2026-01-09T12:07:40+00:00January 9th, 2026|Endpoints News|
New Lilly data suggest Zepbound boosted effect of autoimmune drugnews2026-01-08T19:00:03+00:00January 8th, 2026|Endpoints News|
Ollin’s drug clears retinal disease better than Roche’s Vabysmo in Phase 1b trialnews2026-01-08T13:00:44+00:00January 8th, 2026|Endpoints News|
Immuneering’s pancreatic cancer pill continues to beat standard care, updated first-line data shownews2026-01-07T21:00:19+00:00January 7th, 2026|Endpoints News|
GSK, Ionis say they may have a cure for some hepatitis B patients after Phase 3 winnews2026-01-07T14:42:45+00:00January 7th, 2026|Endpoints News|
Relation, Deerfield to form new companies from discovered drug targetsnews2026-01-07T06:00:17+00:00January 7th, 2026|Endpoints News|
Jazz and Zymeworks spell out HER2 bispecific win news2026-01-06T20:46:28+00:00January 6th, 2026|Endpoints News|
